Immunological considerations for treating globoid cell leukodystrophy-Reference-Cited by-同舟云学术

Immunological considerations for treating globoid cell leukodystrophy

Published:2016-09-17 Issue:11 Volume:94 Page:1349-1358
ISSN:0360-4012
Container-title:Journal of Neuroscience Research
language:en
Short-container-title:Journal of Neuroscience Research

Author:

Karumuthil-Melethil Subha¹,Gray Steven J.¹²

Affiliation:

1. Gene Therapy Center; University of North Carolina; Chapel Hill North Carolina

2. Department of Ophthalmology; University of North Carolina; Chapel Hill North Carolina

Funder

The Legacy of Angels Foundation

Hunter's Hope Foundation

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Reference83 articles.

1. Ultrastructure of experimentally produced globoid cells in the rat;Andrews;Exp Neurol,1970

2. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy;Bambach;Bone Marrow Transplant,1997

3. Molecular triggers of neuroinflammation in mouse models of demyelinating diseases;Barrette;Biol Chem,2013

4. Baskin G Alroy J Li y-T Dayal Y Raghavan SS Sharer L 1989 Galactosylceramide-lipidosis in rhesus monkeys

5. Genetic galactocerebrosidase deficiency (globoid cell leukodystrophy, Krabbe's disease) in rhesus monkeys (Macaca mulatta);Baskin;Lab Anim Sci,1998

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved Brain Pathology and Progressive Peripheral Neuropathy in a 15 Year Old Survivor of Infantile Krabbe Disease Treated With Umbilical Cord Transplantation;Frontiers in Molecular Neuroscience;2022-07-28

2. An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice;Human Gene Therapy;2019-09-01

3. Increased isoprostanoid levels in brain from murine model of Krabbe disease – Relevance of isoprostanes, dihomo-isoprostanes and neuroprostanes to disease severity;Free Radical Biology and Medicine;2019-08

4. Inborn Errors of Metabolism;Fertility Preservation and Restoration for Patients with Complex Medical Conditions;2017